Editorial
Published on 28 Oct 2024
Editorial: Epigenetics of inflammatory reactions and pharmacological modulation
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1505196
- 778 views
- 1 citation
Type at least 3 characters
1,762 articles
Review
Published on 25 Oct 2024
Antioxidant hydrogels for the treatment of osteoarthritis: mechanisms and recent advances
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1488036
- 2,146 views
- 2 citations
Review
Published on 23 Oct 2024
Decoding tumor-fibrosis interplay: mechanisms, impact on progression, and innovative therapeutic strategies
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1491400
- 2,356 views
- 1 citation
Mini Review
Published on 21 Oct 2024
Research progress of knee fibrosis after anterior cruciate ligament reconstruction
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1493155
- 2,023 views
- 1 citation
Clinical Trial
Published on 21 Oct 2024
Efficacy of the cardiac glycoside digoxin as an adjunct to csDMARDs in rheumatoid arthritis patients: a randomized, double-blind, placebo-controlled trial
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1445708
- 1,376 views
Review
Published on 18 Oct 2024
Attenuating mitochondrial dysfunction-derived reactive oxygen species and reducing inflammation: the potential of Daphnetin in the viral pneumonia crisis
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1477680
- 2,294 views
- 1 citation
Original Research
Published on 08 Oct 2024
Causal links between circulatory inflammatory cytokines and risk of digestive polyps: a Mendelian randomization analysis
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1405503
- 1,884 views
Systematic Review
Published on 25 Sep 2024
Systematic review of Janus kinases inhibitors for rheumatoid arthritis: methodology, reporting, and quality of evidence evaluation
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1459511
- 1,590 views
Mini Review
Published on 20 Sep 2024
Inflammation in a ferroptotic environment
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1474285
- 3,474 views
- 7 citations
Original Research
Published on 20 Sep 2024
Protective effect of MP-40 mitigates BDL-induced hepatic fibrosis by inhibiting the NLRP3-mediated pyroptosis
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1479503
- 1,869 views
- 1 citation
Original Research
Published on 18 Sep 2024
Efficacy and safety of calcineurin inhibitors (CNIs) for septic patients in ICU: a cohort study from MIMIC database
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1394553
- 2,667 views
Original Research
Published on 18 Sep 2024
Activation of AMPK/SIRT1/FOXO3a signaling by BMS-477118 (saxagliptin) mitigates chronic colitis in rats: uncovering new anti-inflammatory and antifibrotic roles
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1456058
- 3,108 views
- 3 citations
Original Research
Published on 17 Sep 2024
Impact of SGLT2 inhibitors on lower limb complications: a mendelian randomization perspective
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1401103
- 2,908 views
- 1 citation
Editorial
Published on 17 Sep 2024
Editorial: Modulation of oxidative stress and inflammation via the NRF2 signaling pathway
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1483289
- 969 views
Original Research
Published on 16 Sep 2024
APP-CD74 axis mediates endothelial cell-macrophage communication to promote kidney injury and fibrosis
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1437113
- 8,391 views
- 6 citations
Review
Published on 12 Sep 2024
TLR4 induced TRPM2 mediated neuropathic pain
in Inflammation Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1472771
- 4,775 views
- 1 citation